Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | URGN | IVA | ||
| Company | Colucid Pharma Cmn | Urogen Pharma Ltd | Inventiva S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.50 | 18.63 | 5.93 | ||
| High | 46.55 | 19.03 | 6.06 | ||
| Low | 46.45 | 18.17 | 5.89 | ||
| Latest | 46.53 | 18.14 | 5.92 | ||
| Change | +0.03 | -0.45 | -0.13 | ||
| % Change | +0.06% | -2.42% | -2.07% | ||
| Volume | 127,000 | 148,176 | 178,024 | ||
| 20-Day Average Volume | 245,780 | 898,795 | 270,943 | ||
| Previous Close | 46.50 | 18.59 | 6.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 19.57 | 6.29 | ||
| 20-Day Raw Stochastic | 70.00% | 7.07% | 8.91% | ||
| 20-Day Relative Strength | 67.22 | 41.13 | 46.95 | ||
| Weighted Alpha | +162.70 | +12.14 | +87.54 | ||
| Today's Opinion | N/A | 56% Sell | 56% Buy | ||
| Previous Opinion | N/A | 56% Sell | 56% Buy | ||
| Last Month's Opinion | N/A | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | -1.19% since 03/13/26 | -1.00% since 03/13/26 | ||
| Low | 46.45 on 02/28/17 | 17.95 on 03/18/26 | 5.82 on 03/19/26 | ||
| High | 46.55 on 02/28/17 | 19.25 on 03/17/26 | 6.31 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | -13.53% since 02/20/26 | -12.15% since 02/20/26 | ||
| Low | 46.20 on 01/30/17 | 17.94 on 03/13/26 | 5.82 on 03/19/26 | ||
| High | 46.65 on 02/08/17 | 21.90 on 02/25/26 | 7.05 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | -20.09% since 12/19/25 | +40.86% since 12/19/25 | ||
| Low | 31.25 on 01/06/17 | 17.94 on 03/13/26 | 4.24 on 12/22/25 | ||
| High | 46.65 on 02/08/17 | 24.14 on 12/24/25 | 7.29 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | +1.50% since 09/19/25 | +4.96% since 09/19/25 | ||
| Low | 8.65 on 08/29/16 | 15.86 on 10/10/25 | 3.55 on 11/13/25 | ||
| High | 46.65 on 02/08/17 | 30.00 on 11/26/25 | 7.98 on 10/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 904,998 | 881,544 | ||
| Shares Outstanding, K | 19,280 | 48,682 | 145,951 | ||
| Annual Sales | 0 | 109,790,000 | 15,930,000 | ||
| Annual Net Income | -30,740,000 | -153,490,000 | -199,340,000 | ||
| Last Quarter Sales | N/A | 37,840,000 | 65,000 | ||
| Last Quarter Net Income | N/A | -26,360,000 | -14,296,000 | ||
| 60-Month Beta | 1.51 | 1.34 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.54 on 03/02/26 | N/A on 09/20/21 | ||
| Latest Earnings Date | 03/01/17 | 05/11/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||